Suppr超能文献

一种合成的土拉弗朗西斯菌Tul4和FopA肽混合物在小鼠中诱导体液免疫和细胞介导的免疫反应。

A Synthetic Tul4 and FopA Peptide Cocktail of Francisella tularensis Induces Humoral and Cell-Mediated Immune Responses in Mice.

作者信息

Oh Hanseul, Kim C-Yoon, Kim Chang-Hwan, Hur Gyeung-Haeng, Park Jae-Hak

机构信息

Department of Laboratory Animal Medicine, College of Veterinary Medicine, Seoul National University, Seoul 08826, Republic of Korea.

The 5th R&D Institute-3, Agency for Defense Development, Daejeon 34186, Republic of Korea.

出版信息

J Microbiol Biotechnol. 2016 Sep 28;26(9):1613-9. doi: 10.4014/jmb.1602.02022.

Abstract

Francisella tularensis is a highly virulent pathogen of humans and other mammals. Moreover, F. tularensis has been designated a category A biothreat agent, and there is growing interest in the development of a protective vaccine. In the present study, we determine the in vitro and in vivo immune responses of a subunit vaccine composed of recombinant peptides Tul4 and FopA from epitopes of the F. tularensis outer membrane proteins. The recombinant peptides with adjuvant CpG induced robust immunophenotypic change of dendritic cell (DC) maturation and secretion of inflammatory cytokines (IL-6, IL-12). In addition, the matured DCs enabled ex vivo proliferation of naive splenocytes in a mixed lymphocyte reaction. Lastly, we determined the in vivo immune response by assessment of antibody production in C57BL/ 6 mice. Total IgG levels were produced after immunization and peaked in 6 weeks, and moreover, Tul4-specific IgG was confirmed in the mice receiving peptides with or without CpG. Based on these results, we concluded that the recombinant peptides Tul4 and FopA have immunogenicity and could be a safe subunit vaccine candidate approach against F. tularensis.

摘要

土拉弗朗西斯菌是人类和其他哺乳动物的一种高毒力病原体。此外,土拉弗朗西斯菌已被指定为A类生物威胁因子,人们对开发一种保护性疫苗的兴趣与日俱增。在本研究中,我们测定了一种由来自土拉弗朗西斯菌外膜蛋白表位的重组肽Tul4和FopA组成的亚单位疫苗的体外和体内免疫反应。带有佐剂CpG的重组肽诱导了树突状细胞(DC)成熟的强烈免疫表型变化以及炎性细胞因子(IL-6、IL-12)的分泌。此外,成熟的DC在混合淋巴细胞反应中能够使未活化的脾细胞进行体外增殖。最后,我们通过评估C57BL/6小鼠体内的抗体产生情况来测定体内免疫反应。免疫后产生了总IgG水平,且在6周时达到峰值,此外,在接受有或无CpG肽的小鼠中均证实了Tul4特异性IgG。基于这些结果,我们得出结论,重组肽Tul4和FopA具有免疫原性,可能是一种针对土拉弗朗西斯菌的安全亚单位疫苗候选方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验